NCT06421636: A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
- State
- Under way
- Phase
- Phase 2
- People
- 19 taking part
- Started
- 30 Sep 2024
- Primary completion
- 3 Dec 2026
- Arms
- Part A High Dose, Part A Low Dose, Part B High Dose, Part B Low Dose
- Results
- None posted
- 20 May 2024: Trial registered
- 30 Sep 2024: Trial started